Active Ingredient(s): Apalutamide
FDA Approved: * February 14, 2018
Pharm Company: * JANSSEN BIOTECH
Category: Cancer

Apalutamide, sold under the brand name Erleada among others, is a nonsteroidal antiandrogen (NSAA) medication which is used in the treatment of prostate cancer.[2][5][6][7][8] It is specifically indicated for use in conjunction with castration in the treatment of non-metastatic castration-resistant prostate cancer (NM-CRPC).[2][9][10] It is taken by mouth.[2&... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Erleada 60 mg Oral Tablet, Film Coated
NDC: 59676-600
Janssen Products, Lp
Erleada 240 mg Oral Tablet, Film Coated
NDC: 59676-604
Janssen Products, Lp